RxSight (RXST) last issued guidance on February 25, 2026 for fiscal year 2026. The company guided revenue in the range of $120.00M - $135.00M for the period.

Compared to prior guidance, RxSight raised its revenue forecast from a prior range of $32.60M - $32.60M.

RxSight has issued 30 guidance updates between May 5, 2022 and February 25, 2026. During this period, the company raised its outlook 15 times and lowered it 8 times, providing investors with insight into management's evolving expectations.